DAA (Direct-Acting Antivirals)

Direct-Acting Antivirals (DAAs) are medications used to treat hepatitis C infection by targeting specific steps in the virus's life cycle. They work by blocking proteins essential for the virus to multiply and spread in the body. Unlike older treatments, DAAs are highly effective, often curing hepatitis C in most people with shorter, well-tolerated courses. These drugs have revolutionized hepatitis C management, reducing treatment time and minimizing side effects. Overall, DAAs represent a major advancement in controlling and potentially curing hepatitis C infections.